Breathe Well Live Well
Condition: Asthma
Interventions: Drug: Fluticasone furoate; Drug: Placebo; Drug: Montelukast; Drug: Short Acting Beta 2 Agonist
Sponsor: GlaxoSmithKline
Not yet recruiting – verified August 2016
View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
|
Long-term ICS use in children with asthma slightly impacts annual growth velocity
Healio Using inhaled corticosteroids for more than 12 months in children with asthma appeared to minimally reduce growth velocity and final adult height, according to study results. “Inhaled corticosteroids do not cause much loss of height in children, and … |
View full post on asthma – Google News